|
40 Companies |
|
61 Products |
|
61 Products |
|
49 Mechanisms of Action |
|
0 Trials |
|
203 News |
|
| «12345» |
- Zymafos (palifosfamide) / Alaunos Therap
Enrollment open: Palifosfamide in Treating Patients With Recurrent Germ Cell Tumors (clinicaltrials.gov) - Mar 24, 2013
P2, N=20, Recruiting, Sponsor: Indiana University School of Medicine
Not yet recruiting --> Recruiting
- Proleukin (aldesleukin) / Merck (MSD), Novartis, Iovance Biotherap, Leukine (sargramostim) / Partner Therap
Trial completion: Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer (clinicaltrials.gov) - Mar 20, 2013
P2, N=40, Completed, Sponsor: Cancer Treatment Centers of America
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- Trial termination: Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell Transplant (clinicaltrials.gov) - Mar 13, 2013
P3, N=240, Terminated, Sponsor: OHSU Knight Cancer Institute
Active, not recruiting --> Completed Active, not recruiting --> Terminated
- sunitinib / Generic mfg.
Enrollment change, Metastases: Sunitinib in Treating Patients With Metastatic Germ Cell Tumors That Have Relapsed or Not Responded to Treatment (clinicaltrials.gov) - Mar 7, 2013
P2, N=10, Completed, Sponsor: Memorial Sloan-Kettering Cancer Center
Active, not recruiting --> Terminated N=29 --> 10
- Zymafos (palifosfamide) / Alaunos Therap
New P2 trial: Palifosfamide in Treating Patients With Recurrent Germ Cell Tumors (clinicaltrials.gov) - Mar 7, 2013
P2, N=20, Recruiting, Sponsor: Indiana University School of Medicine
- alvocidib (DSP-2033) / Sumitomo Pharma
Enrollment closed: Alvocidib and Oxaliplatin With or Without Fluorouracil and Leucovorin Calcium in Treating Patients With Relapsed or Refractory Germ Cell Tumors (clinicaltrials.gov) - Mar 3, 2013
P2, N=50, Active, not recruiting, Sponsor: National Cancer Institute (NCI)
N=29 --> 10 Recruiting --> Active, not recruiting
- cefepime hydrochloride / Generic mfg.
Trial completion: Prolonged or Standard Infusion of Cefepime Hydrochloride in Treating Patients With Febrile Neutropenia (clinicaltrials.gov) - Feb 26, 2013
P1, N=70, Completed, Sponsor: Comprehensive Cancer Center of Wake Forest University
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- ||||| Enrollment closed: Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms (clinicaltrials.gov) - Feb 23, 2013
P3, N=456, Active, not recruiting, Sponsor: North Central Cancer Treatment Group
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- Enrollment change: Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Germ Cell Tumors (clinicaltrials.gov) - Feb 21, 2013
P1/2, N=108, Completed, Sponsor: Memorial Sloan-Kettering Cancer Center
Recruiting --> Active, not recruiting N=30 --> 108
- melphalan / Generic mfg.
Trial completion: Melphalan in Patients With Neoplastic Meningitis (clinicaltrials.gov) - Feb 14, 2013
P1, N=6, Completed, Sponsor: Duke University
N=30 --> 108 Active, not recruiting --> Completed
- Enrollment change: Paclitaxel, Ifosfamide, and Carboplatin Followed By Autologous Stem Cell Transplant in Treating Patients With Germ Cell Tumors That Did Not Respond to Cisplatin (clinicaltrials.gov) - Feb 5, 2013
P1/2, N=26, Completed, Sponsor: Memorial Sloan-Kettering Cancer Center
Active, not recruiting --> Completed N=68 --> 26
- Trial completion: Paclitaxel, Ifosfamide, and Carboplatin Followed By Autologous Stem Cell Transplant in Treating Patients With Germ Cell Tumors That Did Not Respond to Cisplatin (clinicaltrials.gov) - Feb 5, 2013
P1/2, N=26, Completed, Sponsor: Memorial Sloan-Kettering Cancer Center
N=68 --> 26 Active, not recruiting --> Completed
- Trial termination, Tumor cell: EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer (clinicaltrials.gov) - Jan 14, 2013
P=N/A, N=30, Terminated, Sponsor: National Cancer Institute (NCI)
Active, not recruiting --> Completed Completed --> Terminated; Administratively complete.
- imatinib / Generic mfg.
Trial termination: Imatinib Mesylate in Treating Patients With Progressive, Refractory, or Recurrent Stage II or Stage III Testicular or Ovarian Cancer (clinicaltrials.gov) - Jan 14, 2013
P2, N=32, Terminated, Sponsor: National Cancer Institute (NCI)
Completed --> Terminated; Administratively complete. Completed --> Terminated; Administratively complete.
- HEOR: Stress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast Cancer (clinicaltrials.gov) - Jan 8, 2013
P=N/A, N=48, Recruiting, Sponsor: Ohio State University Comprehensive Cancer Center
- | New P2 trial: Psychosexual Intervention in Patients With Stage I-III Gynecologic or Breast Cancer (clinicaltrials.gov) - Jan 8, 2013
P2, N=60, Active, not recruiting, Sponsor: Ohio State University Comprehensive Cancer Center
- Yervoy (ipilimumab) / BMS
Trial completion, IO biomarker: Ipilimumab After Allogeneic Stem Cell Transplant in Treating Patients With Persistent or Progressive Cancer (clinicaltrials.gov) - Dec 20, 2012
P1, N=21, Completed, Sponsor: National Cancer Institute (NCI)
Completed --> Terminated; Administratively complete. Suspended --> Completed
- Neulasta (pegfilgrastim) / Roche
Enrollment change: Combination Chemotherapy and Pegfilgrastim in Treating Patients With Previously Untreated Germ Cell Tumors (clinicaltrials.gov) - Dec 2, 2012
P2, N=55, Active, not recruiting, Sponsor: Memorial Sloan-Kettering Cancer Center
Suspended --> Completed N=41 --> 55
- Enrollment change: A Structured Walking Program or Standard Therapy in Cancer Patients Undergoing a Donor Bone Marrow Transplant (clinicaltrials.gov) - Oct 15, 2012
P=N/A, N=115, Completed, Sponsor: Masonic Cancer Center, University of Minnesota
N=41 --> 55 N=90 --> 115
- lapatinib / Generic mfg., albumin-bound paclitaxel / Generic mfg.
Enrollment open, Metastases: Lapatinib and Paclitaxel in Treating Patients With Advanced Solid Tumors (clinicaltrials.gov) - Oct 9, 2012
P1, N=15, Recruiting, Sponsor: University of California, San Francisco
N=90 --> 115 Active, not recruiting --> Recruiting
- | amphotericin b liposome / Generic mfg.
Enrollment change: Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer Patients (clinicaltrials.gov) - Sep 19, 2012
P3, N=115, Completed, Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
Active, not recruiting --> Recruiting N=450 --> 115
- Trial completion: Caspofungin Acetate in Treating Aspergillosis in Patients With Hematologic Cancer or in Patients Who Have Undergone a Stem Cell Transplant (clinicaltrials.gov) - Sep 19, 2012
P2, N=171, Completed, Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
N=450 --> 115 Active, not recruiting --> Completed
- | amphotericin b liposome / Generic mfg.
Trial completion: Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer Patients (clinicaltrials.gov) - Sep 19, 2012
P3, N=115, Completed, Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Ontak (denileukin diftitox) / Eisai, TSD Japan
Enrollment change, Metastases: Cyclophosphamide or Denileukin Diftitox Followed By Expanding a Patient's Own T Cells in the Laboratory in Treating Patients With HER-2/Neu Overexpressing Metastatic Breast Cancer, Ovarian Cancer, or Non-Small Cell Lung Cancer Previously Treated With HER-2/Neu Vaccine (clinicaltrials.gov) - Sep 17, 2012
P1, N=8, Active, not recruiting, Sponsor: University of Washington
Active, not recruiting --> Completed N=10 --> 8
- Trial completion, Surgery, Metastases: Stereotactic Radiosurgery Using CyberKnife in Treating Women With Advanced or Recurrent Gynecological Malignancies (clinicaltrials.gov) - Sep 10, 2012
P2, N=50, Completed, Sponsor: Case Comprehensive Cancer Center
N=10 --> 8 Active, not recruiting --> Completed
- Enrollment change: Palliative Care During Intraperitoneal Chemotherapy in Patients With Ovarian Cancer (clinicaltrials.gov) - Sep 6, 2012
P=N/A, N=17, Completed, Sponsor: City of Hope Medical Center
Active, not recruiting --> Completed N=26 --> 17
- Trial completion: Palliative Care During Intraperitoneal Chemotherapy in Patients With Ovarian Cancer (clinicaltrials.gov) - Sep 6, 2012
P=N/A, N=17, Completed, Sponsor: City of Hope Medical Center
N=26 --> 17 Active, not recruiting --> Completed
- cyclophosphamide / Generic mfg.
Trial completion: Aprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Before a Stem Cell Transplant (clinicaltrials.gov) - Aug 5, 2012
P=N/A, N=40, Completed, Sponsor: Barbara Ann Karmanos Cancer Institute
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Recentin (cediranib) / AstraZeneca, RG4733 / Roche
Enrollment closed, Metastases: Gamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid Tumors (clinicaltrials.gov) - Aug 2, 2012
P1, N=50, Active, not recruiting, Sponsor: National Cancer Institute (NCI)
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- | Enrollment closed: Combination Chemotherapy in Treating Young Patients With Recurrent or Resistant Malignant Germ Cell Tumors (clinicaltrials.gov) - Aug 2, 2012
P2, N=20, Active, not recruiting, Sponsor: Children's Oncology Group
Recruiting --> Active, not recruiting Suspended --> Active, not recruiting
- carboplatin / Generic mfg., gemcitabine / Generic mfg.
New P1 trial, Surgery: Carboplatin, Gemcitabine Hydrochloride, and Stereotactic Body Radiation Therapy in Gynecological Cancer (clinicaltrials.gov) - Jul 26, 2012
P1, N=20, Recruiting, Sponsor: Case Comprehensive Cancer Center
- Trial termination: Yoga in Relieving Fatigue in Patients Undergoing Chemotherapy for Ovarian Cancer (clinicaltrials.gov) - Jul 11, 2012
P=N/A, N=2, Terminated, Sponsor: Comprehensive Cancer Center of Wake Forest University
Suspended --> Active, not recruiting Completed --> Terminated; slow accrual
- Enrollment change: Yoga in Relieving Fatigue in Patients Undergoing Chemotherapy for Ovarian Cancer (clinicaltrials.gov) - Jul 11, 2012
P=N/A, N=2, Terminated, Sponsor: Comprehensive Cancer Center of Wake Forest University
Completed --> Terminated; slow accrual N=100 --> 2
- Trial withdrawal: Mechanical Stimulation in Preventing Bone Density Loss in Patients Undergoing Donor Stem Cell Transplant (clinicaltrials.gov) - Jul 4, 2012
P=N/A, N=0, Withdrawn, Sponsor: Roswell Park Cancer Institute
N=100 --> 2 Not yet recruiting --> Withdrawn
- Trial completion, Metastases: Disease Management Program or Usual Care in Patients With Stage III or Stage IV Lung Cancer, Pancreatic Cancer, Ovarian Cancer, or Colorectal Cancer, and Their Caregivers (clinicaltrials.gov) - Jul 4, 2012
P=N/A, N=605, Completed, Sponsor: Case Comprehensive Cancer Center
Not yet recruiting --> Withdrawn Active, not recruiting --> Completed
- docetaxel / Generic mfg.
Trial completion: Docetaxel in Treating Patients With Recurrent or Refractory Germ Cell Cancer (clinicaltrials.gov) - Jun 28, 2012
P2, N=25, Completed, Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Trial completion: Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor (clinicaltrials.gov) - Jun 12, 2012
P1, N=37, Completed, Sponsor: University of Medicine and Dentistry New Jersey
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Enrollment closed: Lactobacillus in Preventing Infection in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Myelodysplastic Syndrome (clinicaltrials.gov) - Jun 11, 2012
P=N/A, N=30, Active, not recruiting, Sponsor: University of Medicine and Dentistry New Jersey
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- Stroma: Studying Genes in Samples From Younger Patients With Ovarian or Testicular Sex Cord Stromal Tumors (clinicaltrials.gov) - Apr 4, 2012
P=N/A, N=50, Active, not recruiting, Sponsor: Children's Oncology Group
- sirolimus / Generic mfg.
Enrollment open: Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors (clinicaltrials.gov) - Mar 25, 2012
P1, N=30, Recruiting, Sponsor: Roswell Park Cancer Institute
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting
- Trial completion: Ravuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell Transplantation (clinicaltrials.gov) - Mar 6, 2012
P1/2, N=0, Completed, Sponsor: National Institutes of Health Clinical Center (CC)
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- Proleukin (aldesleukin) / Merck (MSD), Novartis, Iovance Biotherap
Trial termination, Metastases: CRUK-PH1/105: Treated Blood Cells, Cyclophosphamide, Fludarabine Phosphate, and Aldesleukin in Treating Patients With Cancer (clinicaltrials.gov) - Feb 26, 2012
P1, N=14, Terminated, Sponsor: Cancer Research UK
Active, not recruiting --> Completed Recruiting --> Terminated; due to safety concerns and lack of efficacy
- Proleukin (aldesleukin) / Merck (MSD), Novartis, Iovance Biotherap
Enrollment change, Metastases: CRUK-PH1/105: Treated Blood Cells, Cyclophosphamide, Fludarabine Phosphate, and Aldesleukin in Treating Patients With Cancer (clinicaltrials.gov) - Feb 26, 2012
P1, N=14, Terminated, Sponsor: Cancer Research UK
Recruiting --> Terminated; due to safety concerns and lack of efficacy N=22 --> 14
- Torisel (temsirolimus) / Pfizer
Enrollment closed, Metastases: Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors (clinicaltrials.gov) - Jan 31, 2012
P1, N=19, Active, not recruiting, Sponsor: University of Southern California
N=22 --> 14 Recruiting --> Active, not recruiting
- sirolimus / Generic mfg.
New P1 trial: Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors (clinicaltrials.gov) - Jan 30, 2012
P1, N=30, Recruiting, Sponsor: Roswell Park Cancer Institute
- Torisel (temsirolimus) / Pfizer
Trial completion, Combination therapy, Metastases: Temsirolimus, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid Tumors (clinicaltrials.gov) - Jan 8, 2012
P1, N=30, Completed, Sponsor: National Cancer Institute (NCI)
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- Decadron (dexamethasone) / Merck (MSD)
Trial completion: Aprepitant in Preventing Nausea and Vomiting in Patients Who Are Undergoing a Stem Cell Transplant (clinicaltrials.gov) - Dec 19, 2011
P=N/A, N=40, Completed, Sponsor: OHSU Knight Cancer Institute
Active, not recruiting --> Completed Active, not recruiting --> Completed
- New P1 trial, Metastases: Phase I Stereotactic Body Radiation for Metastatic or Recurrent Platinum-Resistant Ovarian Cancer (clinicaltrials.gov) - Dec 14, 2011
P1, N=1, Terminated, Sponsor: Stanford University
- cefepime hydrochloride / Generic mfg.
New P1 trial: Prolonged or Standard Infusion of Cefepime Hydrochloride in Treating Patients With Febrile Neutropenia (clinicaltrials.gov) - Nov 30, 2011
P1, N=70, Completed, Sponsor: Comprehensive Cancer Center of Wake Forest University
- Enrollment closed, HEOR: HOPE: Quality of Life and Survivorship Care in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy (HIPEC) (clinicaltrials.gov) - Nov 30, 2011
P=N/A, N=10, Active, not recruiting, Sponsor: Comprehensive Cancer Center of Wake Forest University
Active, not recruiting --> Completed Recruiting --> Active, not recruiting